✦ LIBER ✦

Rituximab And Sargramostim Immunotherapy Following Autologous Stem Cell Transplant For Aggressive Non-Hodgkin's Lymphoma

✍ Scribed by E. Scigliano; C.L. Grosskreutz; K. Osman; A. Malone; J. Nieto; L.M. Isola

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Autologous stem cell transplantation in

✍ C. Gisselbrecht 📂 Article 📅 1996 🏛 Springer 🌐 English ⚖ 169 KB

Adjuvant rituximab causes prolonged hypo

✍ Shortt, J; Spencer, A 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 104 KB

Rituximab-related late-onset neutropenia

✍ Lemieux, B; Tartas, S; Traulle, C; Espinouse, D; Thieblemont, C; Bouafia, F; Alh 📂 Article 📅 2004 🏛 Nature Publishing Group 🌐 English ⚖ 89 KB

Immunotherapy with rituximab during peri

✍ Ian W. Flinn; Paul V. O'Donnell; Amy Goodrich; Georgia Vogelsang; Ross Abrams; S 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 88 KB

Rituximab: Enhancing outcome of autologo

✍ Christian Gisselbrecht; Nicolas Mounier 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 167 KB

Consolidation Therapy Following Autologo

✍ G.A. Colvin; C. Milani; D. Berz; P. Quesenberry 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 49 KB